Slide 1: Q1 2026 Earnings Call
Q1 2026 Earnings Call August 7, 2025 8:30am ET
Slide 2: Today's Hosts
Today's Hosts Andrew Hider Ryan McLeod Chief Executive Officer Chief Financial Officer 2
Slide 3: Forward Looking Statements
Forward Looking Statements Note to Reader: This presentation and the oral statements made during this call contain certain statements that may constitute forward-looking information and forward-looking statements within the meaning of applicable Canadian and United States securities laws ("forward-l
Slide 4: Non-IFRS and Other Financial Measures
Non-IFRS and Other Financial Measures Throughout this presentation management uses certain non-IFRS financial measures, non-IFRS ratios and supplementary financial measures to evaluate the performance of the Company. The terms “EBITDA”, "adjusted revenues", “organic revenue”, “adjusted net income”,
Slide 5: Q1 2026 & Recent Highlights
Q1 2026 & Recent Highlights Organic YOY revenue growth in Life Sciences, Food and Beverage and Consumer ▪ Q1 revenues up ~6% y/y to $736.7M ▪ Q1 Order Bookings¹ of $693M; diversified across market verticals and trailing twelve month book-to-bill ratio1 of 1.17 ▪ Q1 Adj. Earnings from Operations¹ of
Slide 6: Outlook
Outlook Order Backlog1 provides good revenue visibility: • Life Sciences $1,160M: ◦ Funnel remains strong, supported by proven capabilities in regulated markets • Food and Beverage $229M: ◦ Funnel remains strong, and includes primary processing and packaging; continuing to identify opportunities in
Slide 7: Financial Results
Financial Results Y/Y Y/Y Q1 Q1 (C$ M, except per share data) Change Change F2026 F2025 ($) (%) Revenues $736.7 $694.3 $42.4 6.1% Revenue Growth: QTR Earnings from operations 57.8 67.6 (9.8) (14.5)% Organic1 (1.2)% Acquisitions 4.1 % Adjusted earnings from 78.6 86.2 (7.6) (8.8)% FX 3.2 % operations1
Slide 8: Summary
Summary ▪ Strong, diversified Order Backlog1 provides good revenue visibility ▪ Responding to challenges in macro environment; no material impacts on customer Order Bookings or supply chain ▪ Long-term outlook in strategic end-markets remains positive ▪ Priorities and plan remain unchanged during le
Slide 9: ATS
ATS
Slide 10: WATS
WATS
Slide 11: Appendix: Measures
Appendix Reconciliation of Non-IFRS Measures to IFRS Measures 11
Slide 12: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles adjusted EBITDA and EBITDA to the most directly The following table reconciles organic revenue to adjusted revenues, which have comparable IFRS measure (net income) (in millions of dollars): been reconciled
Slide 13: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles adjusted earnings from operations to the most The following table reconciles adjusted basic earnings per share to the most directly comparable IFRS measures (net income) (in millions of dollars): directly c
Slide 14: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles net debt to adjusted EBITDA to the most directly The following table reconciles free cash flow to the most directly comparable comparable IFRS measure (in millions of dollars): IFRS measure (in millions of
Slide 15: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles the previously reported non-IFRS financial measures to reflect the exclusion of the stock-based compensation revaluation expenses: (C$ M) Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 F2024 F2024 F2024 F2025 F2025 F2025 F2025 F2